Severe #COVID in older adults may be due to greater viral load, weaker immune response This age-group may respond more favorably to immunomodulatory therapies aimed at certain inflammatory cytokines, the authors say. cidrap.umn.edu/covid-19/sever…
4
55
119
6K
31
Download Image
@CIDRAP #Gohibic is EMA approved for this very purpose. $IFRX has the approval pending in Europe. $XBI fda.gov/drugs/drug-saf…